• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: JOHNSON & JOHNSON SURGICAL VISION, INC. TECNIS SYMFONY TORIC; MULTIFOCAL IOLS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

JOHNSON & JOHNSON SURGICAL VISION, INC. TECNIS SYMFONY TORIC; MULTIFOCAL IOLS Back to Search Results
Model Number ZXT225
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Blurred Vision (2137); Visual Disturbances (2140); Halo (2227); No Code Available (3191)
Date of Event 12/11/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
If explanted, give date: not applicable, as lens remains implanted.(b)(4).Device evaluation: product evaluation was not preformed because per the initial report the lens is still implanted in the patient's eye.The complaint issue reported could not be verified and no product deficiency could be identified.Manufacturing record review: the manufacturing process record was evaluated and revealed that the product was manufactured and released according to specifications.A search revealed that no other complaints were received from this production order.Conclusion: as a result of the investigation there is no indication of a product quality deficiency and the reported issue could not be verified.All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
 
Event or Problem Description
It was reported that a clinical study patient had bilateral tecnis toric symfony intraocular lenses (iols) implanted.The subject at a 1 month visit reported extremely that she was bothered by starbursts while driving and moderately bothered by glare related to scattered light while driving.In the non-directed ocular visual symptoms the subject complained severe starbursts- both eyes (ou).The monocular uncorrected distance visual acuity (ucdva) ¿ right eye (od) 20/20; left eye (os) 20/20.Monocular best corrected distance visual acuity (bcdva) ¿ od 20/15; os 20/15.However, for the 6 month visit revealed findings of bcdva: 20/20 od; 20/15 os, medical findings significant for posterior capsular opacification (pco) ou, but there was no yttrium aluminum garnet (yag) capsulotomy planned.Also, the subject reported a complaint of ocular visual symptoms as extremely bothered by starbursts ¿ ¿drive at night¿; extremely bothered by glare related to scattered light- ¿drive at night¿.In the non-directed ocular visual symptoms the subject complained of blurred vision/difficulty with vision- overall and near; mild halos; severe starbursts and difficulty with vision in low light in the right eye.The subject did state the symptoms significantly impacted daily activities.Nevertheless, there was still no intervention planned.This mdr report pertains to the right eye (od).A separate report will be submitted for the left eye (os).
 
Additional Manufacturer Narrative
This correction mdr is being submitted to address inaccurate information in section f on the xml version of the previous submission caused by a software glitch in the transmission process.The internal non-conformance numbers for this software issue are nr-0148919 and capa-010215.
 
Additional Manufacturer Narrative
Additional information: section h6: patient code 3191: double vision.Section h6: patient code 3191: photophobia.Upon further follow-up it was learned that the patient is this time moderately bothered by halos- ¿blue halo around moon and stars¿; very bothered by multiple or double vision- ¿seeing far away¿; very bothered by sensitivity to light- ¿driving-reading¿.Yttrium aluminum garnet (yag) capsulotomy is planned for both eyes, but has not yet been scheduled.All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
 
Additional Manufacturer Narrative
Upon further follow-up, yttrium-aluminum garnet (yag) laser, right eye (od) was performed.The subject was seen for follow-up and stated they were doing well and were happy, visual acuity (va) was od 20/20 uncorrected.Section below updated.Section h6: patient code: 3191: yag.All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TECNIS SYMFONY TORIC
Common Device Name
MULTIFOCAL IOLS
Manufacturer (Section D)
JOHNSON & JOHNSON SURGICAL VISION, INC.
1700 e st andrew place
santa ana CA 92705
MDR Report Key9924392
Report Number9614546-2020-00169
Device Sequence Number3296747
Product Code POE
UDI-Device Identifier05050474605688
UDI-Public(01)05050474605688(17)211207
Combination Product (Y/N)Y
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
P980040
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Reporter Type Manufacturer
Report Source health professional,study,use
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date (Section B) 01/08/2021
Report Date (Section F) 01/01/2005
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date12/07/2021
Device Model NumberZXT225
Device Catalogue NumberZXT225U145
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Report to Manufacturer01/10/2005
Initial Date Received by Manufacturer 03/09/2020
Supplement Date Received by Manufacturer10/05/2020
10/25/2020
12/11/2020
Initial Report FDA Received Date04/03/2020
Supplement Report FDA Received Date11/03/2020
11/04/2020
01/09/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age69 YR
Date Report Sent to FDA01/01/2005
-
-